Changes in the mucus barrier during cisplatin-induced intestinal mucositis in rats

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Yamamoto, Hajime ^a   Ishihara, Kazuhiko ^b   Takeda, Yuko ^b   Koizumi, Wasaburo ^a   Ichikawa, Takafumi ^b  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FAMOTIDINE; LAFUTIDINE; MONOCLONAL ANTIBODY; MUCIN; ACETAMIDE DERIVATIVE; PIPERIDINE DERIVATIVE; PYRIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; COLON; CONTROLLED STUDY; DRUG EFFICACY; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL TRACT; GOBLET CELL; HISTOLOGY; ILEUM; IMMUNOREACTIVITY; INTESTINAL MUCOSITIS; JEJUNUM; MALE; MUCOSA INFLAMMATION; NONHUMAN; RAT; SMALL INTESTINE MUCOSA; STOMACH; WEIGHT CHANGE; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HUMAN; INTESTINE MUCOSA; PATHOLOGY;

ACETAMIDES; ANIMALS; CISPLATIN; HUMANS; INTESTINAL MUCOSA; MUCOSITIS; PIPERIDINES; PYRIDINES; RATS;

EID: 84896087919     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/276186     Document Type: Article

References (29)

1. Elting L. S., Cooksley C., Chambers M., Cantor S. B., Manzullo E., Rubenstein E. B., The burdens of cancer therapy: clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 2003 98 7 1531 1539 2-s2.0-0141787012 10.1002/cncr.11671 (Pubitemid 37151510)
2. Slavin R. E., Dias M. A., Saral R., Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols. A clinical-pathologic study of 33 patients. Cancer 1978 42 4 1747 1759 2-s2.0-0018176254 (Pubitemid 9053514)
3. Rubenstein E. B., Peterson D. E., Schubert M., Keefe D., McGuire D., Epstein J., Elting L. S., Fox P. C., Cooksley C., Sonis S. T., Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 2004 100 9 2026 2046 2-s2.0-11144356601 (Pubitemid 38525884)
4. Sartori S., Trevisani L., Nielsen I., Tassinari D., Abbasciano V., Misoprostol and omeprazole in the prevention of chemotherapy-induced acute gastroduodenal mucosal injury. Cancer 1996 78 1447 1482
5. Sartori S., Trevisani L., Nielsen I., Tassinari D., Panzini I., Abbasciano V., Randomized trial of omeprazole or ranitidine versus placebo in the prevention of chemotherapy-induced gastroduodenal injury. Journal of Clinical Oncology 2000 18 3 463 467 2-s2.0-0033951750 (Pubitemid 30078527)
6. Sonis S. T., Elting L. S., Keefe D., Peterson D. E., Schubert M., Hauer-Jensen M., Bekele B. N., Raber-Durlacher J., Donnelly J. P., Rubenstein E. B., Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004 100 9 1995 2025 2-s2.0-11144356545 (Pubitemid 38528741)
7. 2-receptor antagonists with gastric mucosal defensive properties. Mini-Reviews in Medicinal Chemistry 2009 9 5 581 589 2-s2.0-67649892035 10.2174/138955709788167646
8. Homesley H. D., Gainey J. M., Jobson V. W., Welander C. E., Muss H. B., Wells H. B., Cisplatin chemotherapy and emesis in patients given metoclopramide and controls. The New England Journal of Medicine 1982 307 250 251
9. Hesketh P. J., Gandara D. R., Serotonin antagonists: a new class of antiemetic agents. Journal of the National Cancer Institute 1991 83 9 613 620 2-s2.0-0025760561
10. Korenaga D., Honda M., Yasuda M., Inutsuka S., Nozoe T., Tashiro H., Increased intestinal permeability correlates with gastrointestinal toxicity among formulations of the fluorouracil analogue tegafur in rats. European Surgical Research 2002 34 5 351 356 2-s2.0-0036392102 10.1159/000064001
11. Pritchard D. M., Potten C. S., Hickman J. A., The relationships between p53-dependent apoptosis, inhibition of proliferation, and 5-fluorouracil-induced histopathology in murine intestinal epithelia. Cancer Research 1998 58 23 5453 5465 2-s2.0-0032404145 (Pubitemid 28551130)
12. Saegusa Y., Ichikawa T., Iwai T., Goso Y., Ikezawa T., Nakano M., Shikama N., Saigenji K., Ishihara K., Effects of acid antisecretory drugs on mucus barrier of the rat against 5-fluorouracil-induced gastrointestinal mucositis. Scandinavian Journal of Gastroenterology 2008 43 5 531 537 2-s2.0-42149195078 10.1080/00365520701811693 (Pubitemid 351536043)
13. Vickers A. E. M., Rose K., Fisher R., Saulnier M., Sahota P., Bentley P., Kidney slices of human and rat to characterize cisplatin-induced injury on cellular pathways and morphology. Toxicologic Pathology 2004 32 5 577 590 2-s2.0-4544290091 10.1080/01926230490508821 (Pubitemid 39258463)
14. Singh G., A possible cellular mechanism of cisplatin-induced nephrotoxicity. Toxicology 1989 58 1 71 80 2-s2.0-0024443101 (Pubitemid 19233700)
15. Azuumi Y., Ohara S., Ishihara K., Okabe H., Hotta K., Correlation of quantitative changes of gastric mucosal glycoproteins with aspirin-induced gastric damage in rats. Gut 1980 21 6 533 536 2-s2.0-0018897002 (Pubitemid 10059416)
16. 2 receptor antagonist, FRG-8813, on gastric mucin in rats with or without acidified ethanol-induced gastric damage. Life Sciences 1994 54 10 159 164 2-s2.0-0028301739 (Pubitemid 24078922)
17. Kojima Y., Ishihara K., Ohara S., Saigenji K., Hotta K., Effects of the M1 muscarinic receptor antagonist pirenzepine on gastric mucus glycoprotein in rats with or without ethanol-induced gastric damage. Scandinavian Journal of Gastroenterology 1992 27 9 764 768 2-s2.0-0026616791
18. Saegusa Y., Ichikawa T., Iwai T., Goso Y., Okayasu I., Ikezawa T., Shikama N., Saigenji K., Ishihara K., Changes in the mucus barrier of the rat during 5-fluorouracil-induced gastrointestinal mucositis. Scandinavian Journal of Gastroenterology 2008 43 1 59 65 2-s2.0-37549072675 10.1080/00365520701579662
19. Ishihara K., Kurihara M., Goso Y., Ota H., Katsuyama T., Hotta K., Establishment of monoclonal antibodies against carbohydrate moiety of gastric mucins distributed in the different sites and layers of rat gastric mucosa. Glycoconjugate Journal 1996 13 5 857 864 2-s2.0-0029839147 10.1007/BF00702350 (Pubitemid 26354279)
20. Tsubokawa D., Goso Y., Sawaguchi A., Kurihara M., Ichikawa T., Sato N., Suganuma T., Hotta K., Ishihara K., A monoclonal antibody, PGM34, against 6-sulfated blood-group H type 2 antigen, on the carbohydrate moiety of mucin: analysis of the epitope sequence and immunohistochemical study. FEBS Journal 2007 274 7 1833 1848 2-s2.0-33947240786 10.1111/j.1742-4658.2007.05731.x (Pubitemid 46426918)
21. Ota H., Katsuyama T., Alternating laminated array of two types of mucin in the human gastric surface mucous layer. Histochemical Journal 1992 24 2 86 92 2-s2.0-0026586024
22. Gerdes J., Lemke H., Baisch H., Wacker H. H., Schwab U., Stein H., Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67. Journal of Immunology 1984 133 4 1710 1715 2-s2.0-0021212003 (Pubitemid 14035254)
23. Gerlach C., Golding M., Larue L., Alison M. R., Gerdes J., Ki-67 immunoexpression is a robust marker of proliferative cells in the rat. Laboratory Investigation 1997 77 6 697 698 2-s2.0-0031461106 (Pubitemid 28018791)
24. Gerlach C., Sakkab D. Y., Scholzen T., Daßler R., Alison M. R., Gerdes J., Ki-67 expression during rat liver regeneration after partial hepatectomy. Hepatology 1997 26 3 573 578 2-s2.0-0030866198 (Pubitemid 27392346)
25. Tazuke Y., Maeda K., Wasa M., Satoko N., Fukuzawa M., Protective mechanism of glutamine on the expression of proliferating cell nuclear antigen after cisplatin-induced intestinal mucosal injury. Pediatric Surgery International 2011 27 2 151 158 2-s2.0-78751650305 10.1007/s00383-010-2798-8
26. Miyamoto Y., Miyamoto M., Immunohistochemical localizations of secretin, cholecystokinin, and somatostatin in the rat small intestine after acute cisplatin treatment. Experimental and Molecular Pathology 2004 77 3 238 245 2-s2.0-7044262094 10.1016/j.yexmp.2004.05.007 (Pubitemid 39422625)
27. Miyamoto Y., Miyamoto M., Immunohistochemical localizations of secretin, cholecystokinin, and somatostatin in the rat small intestine after acute cisplatin treatment. Experimental and Molecular Pathology 2004 77 3 238 245 2-s2.0-7044262094 10.1016/j.yexmp.2004.05.007 (Pubitemid 39422625)
28. 2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa. Journal of Gastroenterology and Hepatology 2007 22 11 1800 1805 2-s2.0-34948841931 10.1111/j.1440-1746.2006.04721.x (Pubitemid 47525074)
29. Bodiga V. L., Bodiga S., Surampudi S., Boindala S., Putcha U., Nagalla B., Subramaniam K., Manchala R., Effect of vitamin supplementation on cisplatin-induced intestinal epithelial cell apoptosis in Wistar/NIN rats. Nutrition 2012 28 5 572 580 2-s2.0-84859217023 10.1016/j.nut.2011.09.007